Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
Infectious Disease Clinics of North America|October 23, 2012
Care of the cirrhotic patientSyed-Mohammed Jafri, Stuart C Gordon
Clinics in Liver Disease|April 5, 2020
Novel Therapies in Hepatic EncephalopathyMaryam Alimirah, Omar Sadiq, Stuart C Gordon
Digestive Diseases and Sciences|November 17, 2014
The consequences of cirrhosis in AmericaSyed-Mohammed R Jafri, Stuart C Gordon
Clinical Liver Disease|July 28, 2020
Management of Direct-Acting Antiviral FailuresMaryam Alimirah, Omar Sadiq, Stuart C Gordon
Clinical Liver Disease|June 13, 2019
Is there still a role for liver biopsy in managing hepatitis C virus infections?Syed-Mohammed R Jafri, Stuart C Gordon
Expert Opinion on Pharmacotherapy|August 7, 2024
Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitisAllyce Caines, Sheri Trudeau, Stuart C Gordon
Expert Opinion on Pharmacotherapy|January 17, 2012
Adefovir dipivoxil in chronic hepatitis B: history and current usesMaria C Segovia, Wadih Chacra, Stuart C Gordon
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2016
Pharmacodynamics and pharmacokinetics of elbasvir and grazoprevir in the treatment of hepatitis CNimisha Sulejmani, Syed-Mohammed Jafri, Stuart C Gordon
Journal of Clinical Gastroenterology|April 19, 2003
Successful treatment of hepatitis B-associated vasculitis with lamivudineVeslav Stecevic, Martin M Pevzner, Stuart C Gordon
The Journal of Infectious Diseases|April 27, 2021
Changing Trends in the United States Prevalence of Hepatitis B Core Antibody Provide Important Perspectives Into Future Screening and Vaccination StrategiesHumberto C Gonzalez, Sheri Trudeau, Stuart C Gordon
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Infectious Disease Clinics of North America|October 23, 2012
Care of the cirrhotic patientSyed-Mohammed Jafri, Stuart C Gordon
Clinics in Liver Disease|April 5, 2020
Novel Therapies in Hepatic EncephalopathyMaryam Alimirah, Omar Sadiq, Stuart C Gordon
Digestive Diseases and Sciences|November 17, 2014
The consequences of cirrhosis in AmericaSyed-Mohammed R Jafri, Stuart C Gordon
Clinical Liver Disease|July 28, 2020
Management of Direct-Acting Antiviral FailuresMaryam Alimirah, Omar Sadiq, Stuart C Gordon
Clinical Liver Disease|June 13, 2019
Is there still a role for liver biopsy in managing hepatitis C virus infections?Syed-Mohammed R Jafri, Stuart C Gordon
Expert Opinion on Pharmacotherapy|August 7, 2024
Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitisAllyce Caines, Sheri Trudeau, Stuart C Gordon
Expert Opinion on Pharmacotherapy|January 17, 2012
Adefovir dipivoxil in chronic hepatitis B: history and current usesMaria C Segovia, Wadih Chacra, Stuart C Gordon
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2016
Pharmacodynamics and pharmacokinetics of elbasvir and grazoprevir in the treatment of hepatitis CNimisha Sulejmani, Syed-Mohammed Jafri, Stuart C Gordon
Journal of Clinical Gastroenterology|April 19, 2003
Successful treatment of hepatitis B-associated vasculitis with lamivudineVeslav Stecevic, Martin M Pevzner, Stuart C Gordon
The Journal of Infectious Diseases|April 27, 2021
Changing Trends in the United States Prevalence of Hepatitis B Core Antibody Provide Important Perspectives Into Future Screening and Vaccination StrategiesHumberto C Gonzalez, Sheri Trudeau, Stuart C Gordon
Pageof 22